UK markets closed
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • FTSE 250

    20,961.31
    -334.92 (-1.57%)
     
  • AIM

    1,163.26
    -10.13 (-0.86%)
     
  • GBP/EUR

    1.1617
    +0.0020 (+0.17%)
     
  • GBP/USD

    1.3827
    -0.0067 (-0.48%)
     
  • BTC-GBP

    34,329.14
    -317.89 (-0.92%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • DOW

    31,496.30
    +572.16 (+1.85%)
     
  • CRUDE OIL

    66.28
    +2.45 (+3.84%)
     
  • GOLD FUTURES

    1,698.20
    -2.50 (-0.15%)
     
  • NIKKEI 225

    28,864.32
    -65.78 (-0.23%)
     
  • HANG SENG

    29,098.29
    -138.50 (-0.47%)
     
  • DAX

    13,920.69
    -135.65 (-0.97%)
     
  • CAC 40

    5,782.65
    -48.00 (-0.82%)
     

Global Clinical Microbiology Instruments and Reagents Industry

ReportLinker
·23-min read

What`s the Role of Clinical Microbiology in Understanding Corona virus Pathogenesis? As the corona virus surges across the globe, vigilance and elevated corona virus response activities will continue unabated.

New York, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Clinical Microbiology Instruments and Reagents Industry" - https://www.reportlinker.com/p05957366/?utm_source=GNW
Laboratories the world over are busy and have been kept open all through the lockdown period as the race to test for infections and develop drugs, diagnostics, and vaccines continues with undiminished fervor. While industrial laboratories were shut down as part of the containment measures, microbiology labs, virology labs, clinical testing labs, research labs and academic labs have been actively involved in the global fight against the pandemic. Against this backdrop, the global market for Clinical Microbiology will reach a projected market size of US6.1 billion by the year 2027, trailing a CAGR of 6.4%. As COVID-19 antiviral drugs and vaccine development intensifies, billions of dollars are being invested in over 100 vaccine candidates forcing labs to work at full and extended capacity. Scientists across the worlds are working away in labs analyzing data and finding newer ways to advance their corona virus research projects. By isolating and differentiating microorganisms, clinical microbiology plays a pivotal role in supporting the global response against COVID-19. The ability to quickly and easily classify a deadly virus like COVID-19 in minutes is of immense importance in planning and mobilizing medical needs.

Efforts to carry out a complete genome sequencing of SARS-CoV-2 are being ramped up, while the world waits in agony for medical solutions against the infection. Cracking the COVID-19 genome signature is an essential arsenal in the toolkit for diagnostics, vaccine and drug development. With rapid and accurate diagnosis of SARS-CoV-2 expected to assist in the control of the outbreak, microbiology labs worldwide are racing to test billions of samples. The COVID-19 serology race is getting bigger and faster. Serology tests remain important as it supports community surveillance efforts by playing a key role in identifying individuals with past COVID-19 infections. Responding in droves are developers racing to develop new COVID-19 antibody tests, and laboratories preparing to test samples. The U. S. and Europe together account for a major chunk of the global market. Growth in the coming years will stem from developing countries in Asia Pacific, Latin America, and the Middle East, driven by increasing automation and growing use of rapid microbiological tests.

Unprepared for the Current Pandemic, A Wiser World in the Post COVID-19 Era Will Stand Committed to Virology, Research, & Healthcare

The healthcare and medical system in most parts of the world are in crisis after decades of neglect. With the pandemic exposing the under-preparedness of health systems worldwide, the healthcare industry has suddenly emerged into a key focus area. Governments worldwide have voiced plans to strengthen the healthcare system. Already governments have announced budgetary support to strengthen the health system`s response to COVID-19. From stepping up clinical research activities to constructing new hospitals and procuring critical care life support devices, several measures are being implemented. The world will need to double its healthcare coverage in the coming years. Countries worldwide will need to intensify efforts to expand healthcare services and increase spending to least an additional 1.5% to 2.0% of GDP on primary care than current spends to ensure universal health coverage by 2030. The scenario brings good news for the clinical microbiology market as it brings new opportunities for demand growth of instruments and reagents. Asia-Pacific is expected to emerge as the fastest growing market for automated and rapid microbiological tests. Emerging nations, such as China, India, and Brazil, present significant opportunities due to their constantly growing healthcare infrastructure. In the post COVID-19 period, Asia will record growth supported by the rising prevalence of various pathogenic diseases, need to accelerate microbiological testing and discovery of adapting and mutating bacterium. Currently, clinical microbiology is widely used in Asia to identify fungal, bacterial and parasitic infections. Focus on healthcare reforms, emphasis on controlling costs of public hospitals, continuous rise in number of patients at primary healthcare centers, and rapid growth of private hospitals will spur growth of independent clinical diagnostics automation.

Competitors identified in this market include, among others,

  • 3M Company

  • Abbott Laboratories

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • bioMerieux SA

  • Bio-Rad Laboratories, Inc.

  • Bruker Corporation

  • Danaher Corporation

  • Hologic, Inc.

  • Merck KgaA

  • Neogen Corporation

  • Qiagen NV

  • Roche Diagnostics (Schweiz) AG

  • Shimadzu Corporation

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p05957366/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE I-1

II. EXECUTIVE SUMMARY II-1

1. MARKET OVERVIEW II-1
Impact of Covid-19 and a Looming Global Recession II-1
Exhibit 1: The World of Clinical Microbiology Gains Sudden
Prominence as Scientists Mobilize United Efforts to Find Ways
to Detect, Treat & Vaccinate People Against the Novel
Coronavirus: Global Scale of Daily Testing Vs Confirmed
Cases Per Million II-3
Clinical Microbiology: An Introduction II-3
Outlook: Evolutionary Battle against Microbes Drives Market Future II-4
Instant Detection of Pathogens : A New Epoch in the Fight for
Survival II-5
Reagents Account for Major Share II-6
Asia-Pacific Drives Future Growth II-6
Recent Market Activity II-7
World Brands II-8

2. FOCUS ON SELECT PLAYERS II-11

3. MARKET TRENDS & DRIVERS II-12
Microbiology Laboratories Switch to Automation to Push Yields II-12
Exhibit 2: World Laboratory Automation Market in US$ Billion
for Years 2018, 2020, 2022, 2024 & 2026 II-13
Clinical Microbiology Market Benefits from Digitalization and
Robotization Trend II-14
Integration of Clinical Microbiology with Cloud Computing II-14
Artificial Intelligence Holds Positive Implications for
Automation of Clinical Microbiology II-15
Advancements in Molecular Diagnostics Drive Market Growth II-15
Emerging Technologies in Clinical Microbiology Diagnostics Aim
at Faster Diagnosis II-16
Technological Advances Crucial to Sustain Future Market Growth II-17
Rapid Diagnostics Bring in a Transformation II-18
Automated and Rapid Microbiological Tests Revolutionize
Microbiological Testing II-19
Traditional Rapid Microbiological Tests Make Way for New, Probe
Tests II-20
Antibiotic Resistant Bacteria Throws the Spotlight on Microbial
Testing II-20
Research in Stem Cell Technology, and Regenerative Medicine
Expand Growth Opportunities II-21
Exhibit 3: Stem Cell Banking Global Market Estimates and
Forecasts in US$ Billion: 2020, 2022 & 2024 II-22
Greater Number of Tests for HIV and Sexually Transmitted
Diseases Amplify Growth II-22
Exhibit 4: Global HIV Prevalence: Number of People Living with
AIDs (in Thousands) by Region for 2018 II-23
Exhibit 5: Number of AIDS-Related Deaths (in Thousands) by
Region for 2018 II-24
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer
Disease II-24
Home HIV Testing Emerges as a Lucrative Option II-25
Increasing Incidence of Infectious Diseases Drives Growth II-25
Exhibit 6: Infectious Diseases Remain Major Cause of Death in
Under Developed Regions: Breakdown of Leading Causes of Death
in Sub-Saharan Africa (in %) II-27
Exhibit 7: Infectious Diseases Related Mortality High Among
Children Below 5 Years: Breakdown of Leading Causes of Death
in Children Below 5 Years (in %) II-28
Increasing Prevalence of Respiratory Infections Drive Growth II-28
Exhibit 8: Global Number of Deaths Caused Due to Communicable
Diseases (In 000s) II-29
Influenza Boosts Rapid Test Prospects II-30
Exhibit 9: Flu Related CDC Estimates from October 2019-April4,
2020 II-30
Rise in Prevalence of COPD Augments Demand II-30
Exhibit 10: Global Prevalence of COPD by Age Group: Percentage
of Men and Women Affected by the Condition II-31
Rise in Pollution Levels Trigger Increase in Respiratory Diseases II-32
Exhibit 11: World Ranking of Most Polluted Countries: 2019 II-33
Exhibit 12: Percentage Share Breakdown of Global Deaths Linked
to Air Pollution II-34
Increase in Healthcare Spending in Emerging Markets to Propel
Demand II-34
Exhibit 13: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023 II-36
Demographic Shifts & Societal Changes Drive Demand for Test
Volumes II-36
Exhibit 14: Elderly Healthcare Expenditure as a % of GDP II-37
Exhibit 15: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050 II-38
Exhibit 16: Life Expectancy at Age 60 and 80 Years: (2010-2015),
(2020-2025) & (2045-2050) II-38

4. GLOBAL MARKET PERSPECTIVE II-39
Table 1: Clinical Microbiology Instruments and Reagents Global
Market Estimates and Forecasts in US$ Thousand by
Region/Country: 2020-2027 II-39

Table 2: Clinical Microbiology Instruments and Reagents Global
Retrospective Market Scenario in US$ Thousand by
Region/Country: 2012-2019 II-40

Table 3: Clinical Microbiology Instruments and Reagents Market
Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
2027 II-41

Table 4: Instruments World Market by Region/Country in US$
Thousand: 2020 to 2027 II-42

Table 5: Instruments Historic Market Analysis by Region/Country
in US$ Thousand: 2012 to 2019 II-43

Table 6: Instruments Market Share Breakdown of Worldwide Sales
by Region/Country: 2012 VS 2020 VS 2027 II-44

Table 7: Reagents Potential Growth Markets Worldwide in US$
Thousand: 2020 to 2027 II-45

Table 8: Reagents Historic Market Perspective by Region/Country
in US$ Thousand: 2012 to 2019 II-46

Table 9: Reagents Market Sales Breakdown by Region/Country in
Percentage: 2012 VS 2020 VS 2027 II-47

Table 10: Respiratory Diseases Geographic Market Spread
Worldwide in US$ Thousand: 2020 to 2027 II-48

Table 11: Respiratory Diseases Region Wise Breakdown of Global
Historic Demand in US$ Thousand: 2012 to 2019 II-49

Table 12: Respiratory Diseases Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027 II-50

Table 13: Bloodstream Infections World Market Estimates and
Forecasts by Region/Country in US$ Thousand: 2020 to 2027 II-51

Table 14: Bloodstream Infections Market Historic Review by
Region/Country in US$ Thousand: 2012 to 2019 II-52

Table 15: Bloodstream Infections Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027 II-53

Table 16: Gastrointestinal Diseases World Market by
Region/Country in US$ Thousand: 2020 to 2027 II-54

Table 17: Gastrointestinal Diseases Historic Market Analysis by
Region/Country in US$ Thousand: 2012 to 2019 II-55

Table 18: Gastrointestinal Diseases Market Share Distribution
in Percentage by Region/Country: 2012 VS 2020 VS 2027 II-56

Table 19: Sexually Transmitted Diseases World Market Estimates
and Forecasts in US$ Thousand by Region/Country: 2020 to 2027 II-57

Table 20: Sexually Transmitted Diseases Market Worldwide
Historic Review by Region/Country in US$ Thousand: 2012 to 2019 II-58

Table 21: Sexually Transmitted Diseases Market Percentage Share
Distribution by Region/Country: 2012 VS 2020 VS 2027 II-59

Table 22: Urinary Tract Infections Market Opportunity Analysis
Worldwide in US$ Thousand by Region/Country: 2020 to 2027 II-60

Table 23: Urinary Tract Infections Global Historic Demand in
US$ Thousand by Region/Country: 2012 to 2019 II-61

Table 24: Urinary Tract Infections Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027 II-62

Table 25: Other Disease Areas World Market by Region/Country in
US$ Thousand: 2020 to 2027 II-63

Table 26: Other Disease Areas Historic Market Analysis by
Region/Country in US$ Thousand: 2012 to 2019 II-64

Table 27: Other Disease Areas Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 II-65

Table 28: Hospitals & Diagnostic Centers Global Market
Estimates & Forecasts in US$ Thousand by Region/Country:
2020-2027 II-66

Table 29: Hospitals & Diagnostic Centers Retrospective Demand
Analysis in US$ Thousand by Region/Country: 2012-2019 II-67

Table 30: Hospitals & Diagnostic Centers Market Share Breakdown
by Region/Country: 2012 VS 2020 VS 2027 II-68

Table 31: Custom Lab Service Providers Demand Potential
Worldwide in US$ Thousand by Region/Country: 2020-2027 II-69

Table 32: Custom Lab Service Providers Historic Sales Analysis
in US$ Thousand by Region/Country: 2012-2019 II-70

Table 33: Custom Lab Service Providers Share Breakdown Review
by Region/Country: 2012 VS 2020 VS 2027 II-71

Table 34: Academic & Research Institutes Worldwide Latent
Demand Forecasts in US$ Thousand by Region/Country: 2020-2027 II-72

Table 35: Academic & Research Institutes Global Historic
Analysis in US$ Thousand by Region/Country: 2012-2019 II-73

Table 36: Academic & Research Institutes Distribution of Global
Sales by Region/Country: 2012 VS 2020 VS 2027 II-74

III. MARKET ANALYSIS III-1

GEOGRAPHIC MARKET ANALYSIS III-1

UNITED STATES III-1
Market Overview III-1
Exhibit 17: Healthcare Spending as a % of GDP in the US: 2010-2020 III-2
COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests III-2
Market Analytics III-4
Table 37: United States Clinical Microbiology Instruments and
Reagents Market Estimates and Projections in US$ Thousand by
Product: 2020 to 2027 III-4

Table 38: Clinical Microbiology Instruments and Reagents Market
in the United States by Product: A Historic Review in US$
Thousand for 2012-2019 III-5

Table 39: United States Clinical Microbiology Instruments and
Reagents Market Share Breakdown by Product: 2012 VS 2020 VS
2027 III-6

Table 40: United States Clinical Microbiology Instruments and
Reagents Market Estimates and Projections in US$ Thousand by
Disease Area: 2020 to 2027 III-7

Table 41: Clinical Microbiology Instruments and Reagents Market
in the United States by Disease Area: A Historic Review in US$
Thousand for 2012-2019 III-8

Table 42: United States Clinical Microbiology Instruments and
Reagents Market Share Breakdown by Disease Area: 2012 VS 2020
VS 2027 III-9

Table 43: United States Clinical Microbiology Instruments and
Reagents Latent Demand Forecasts in US$ Thousand by End-Use:
2020 to 2027 III-10

Table 44: Clinical Microbiology Instruments and Reagents
Historic Demand Patterns in the United States by End-Use in US$
Thousand for 2012-2019 III-11

Table 45: Clinical Microbiology Instruments and Reagents Market
Share Breakdown in the United States by End-Use: 2012 VS 2020
VS 2027 III-12

CANADA III-13
Table 46: Canadian Clinical Microbiology Instruments and
Reagents Market Estimates and Forecasts in US$ Thousand by
Product: 2020 to 2027 III-13

Table 47: Canadian Clinical Microbiology Instruments and
Reagents Historic Market Review by Product in US$ Thousand:
2012-2019 III-14

Table 48: Clinical Microbiology Instruments and Reagents Market
in Canada: Percentage Share Breakdown of Sales by Product for
2012, 2020, and 2027 III-15

Table 49: Canadian Clinical Microbiology Instruments and
Reagents Market Estimates and Forecasts in US$ Thousand by
Disease Area: 2020 to 2027 III-16

Table 50: Canadian Clinical Microbiology Instruments and
Reagents Historic Market Review by Disease Area in US$
Thousand: 2012-2019 III-17

Table 51: Clinical Microbiology Instruments and Reagents Market
in Canada: Percentage Share Breakdown of Sales by Disease Area
for 2012, 2020, and 2027 III-18

Table 52: Canadian Clinical Microbiology Instruments and
Reagents Market Quantitative Demand Analysis in US$ Thousand by
End-Use: 2020 to 2027 III-19

Table 53: Clinical Microbiology Instruments and Reagents Market
in Canada: Summarization of Historic Demand Patterns in US$
Thousand by End-Use for 2012-2019 III-20

Table 54: Canadian Clinical Microbiology Instruments and
Reagents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 III-21

JAPAN III-22
Market Overview III-22
Covid-19 Testing Market in Japan III-22
Demographics Drive Market Growth III-22
Exhibit 18: Breakdown of Population by Age Group in Japan:
2010, 2020, and 2025 III-23
Market Analytics III-24
Table 55: Japanese Market for Clinical Microbiology Instruments
and Reagents: Annual Sales Estimates and Projections in US$
Thousand by Product for the Period 2020-2027 III-24

Table 56: Clinical Microbiology Instruments and Reagents Market
in Japan: Historic Sales Analysis in US$ Thousand by Product
for the Period 2012-2019 III-25

Table 57: Japanese Clinical Microbiology Instruments and
Reagents Market Share Analysis by Product: 2012 VS 2020 VS 2027 III-26

Table 58: Japanese Market for Clinical Microbiology Instruments
and Reagents: Annual Sales Estimates and Projections in US$
Thousand by Disease Area for the Period 2020-2027 III-27

Table 59: Clinical Microbiology Instruments and Reagents Market
in Japan: Historic Sales Analysis in US$ Thousand by Disease
Area for the Period 2012-2019 III-28

Table 60: Japanese Clinical Microbiology Instruments and
Reagents Market Share Analysis by Disease Area: 2012 VS 2020 VS
2027 III-29

Table 61: Japanese Demand Estimates and Forecasts for Clinical
Microbiology Instruments and Reagents in US$ Thousand by
End-Use: 2020 to 2027 III-30

Table 62: Japanese Clinical Microbiology Instruments and
Reagents Market in US$ Thousand by End-Use: 2012-2019 III-31

Table 63: Clinical Microbiology Instruments and Reagents Market
Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 III-32

CHINA III-33
Market Overview III-33
Covid-19 Testing Market III-33
Market Analytics III-34
Table 64: Chinese Clinical Microbiology Instruments and
Reagents Market Growth Prospects in US$ Thousand by Product for
the Period 2020-2027 III-34

Table 65: Clinical Microbiology Instruments and Reagents
Historic Market Analysis in China in US$ Thousand by Product:
2012-2019 III-35

Table 66: Chinese Clinical Microbiology Instruments and
Reagents Market by Product: Percentage Breakdown of Sales for
2012, 2020, and 2027 III-36

Table 67: Chinese Clinical Microbiology Instruments and
Reagents Market Growth Prospects in US$ Thousand by Disease
Area for the Period 2020-2027 III-37

Table 68: Clinical Microbiology Instruments and Reagents
Historic Market Analysis in China in US$ Thousand by Disease
Area: 2012-2019 III-38

Table 69: Chinese Clinical Microbiology Instruments and
Reagents Market by Disease Area: Percentage Breakdown of Sales
for 2012, 2020, and 2027 III-39

Table 70: Chinese Demand for Clinical Microbiology Instruments
and Reagents in US$ Thousand by End-Use: 2020 to 2027 III-40

Table 71: Clinical Microbiology Instruments and Reagents Market
Review in China in US$ Thousand by End-Use: 2012-2019 III-41

Table 72: Chinese Clinical Microbiology Instruments and
Reagents Market Share Breakdown by End-Use: 2012 VS 2020 VS
2027 III-42

EUROPE III-43
Market Overview III-43
COVID-19 Pandemic Propels Demand III-43
Growth in Clinical Diagnostics Automation III-43
Rise in Automated, and Rapid Tests in Clinical Applications III-44
Ageing Demography: An Opportunity Indicator III-45
Market Analytics III-46
Table 73: European Clinical Microbiology Instruments and
Reagents Market Demand Scenario in US$ Thousand by
Region/Country: 2020-2027 III-46

Table 74: Clinical Microbiology Instruments and Reagents Market
in Europe: A Historic Market Perspective in US$ Thousand by
Region/Country for the Period 2012-2019 III-47

Table 75: European Clinical Microbiology Instruments and
Reagents Market Share Shift by Region/Country: 2012 VS 2020 VS
2027 III-48

Table 76: European Clinical Microbiology Instruments and
Reagents Market Estimates and Forecasts in US$ Thousand by
Product: 2020-2027 III-49

Table 77: Clinical Microbiology Instruments and Reagents Market
in Europe in US$ Thousand by Product: A Historic Review for the
Period 2012-2019 III-50

Table 78: European Clinical Microbiology Instruments and
Reagents Market Share Breakdown by Product: 2012 VS 2020 VS
2027 III-51

Table 79: European Clinical Microbiology Instruments and
Reagents Market Estimates and Forecasts in US$ Thousand by
Disease Area: 2020-2027 III-52

Table 80: Clinical Microbiology Instruments and Reagents Market
in Europe in US$ Thousand by Disease Area: A Historic Review
for the Period 2012-2019 III-53

Table 81: European Clinical Microbiology Instruments and
Reagents Market Share Breakdown by Disease Area: 2012 VS 2020
VS 2027 III-54

Table 82: European Clinical Microbiology Instruments and
Reagents Addressable Market Opportunity in US$ Thousand by
End-Use: 2020-2027 III-55

Table 83: Clinical Microbiology Instruments and Reagents Market
in Europe: Summarization of Historic Demand in US$ Thousand by
End-Use for the Period 2012-2019 III-56

Table 84: European Clinical Microbiology Instruments and
Reagents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 III-57

FRANCE III-58
Table 85: Clinical Microbiology Instruments and Reagents Market
in France by Product: Estimates and Projections in US$ Thousand
for the Period 2020-2027 III-58

Table 86: French Clinical Microbiology Instruments and Reagents
Historic Market Scenario in US$ Thousand by Product: 2012-2019 III-59

Table 87: French Clinical Microbiology Instruments and Reagents
Market Share Analysis by Product: 2012 VS 2020 VS 2027 III-60

Table 88: Clinical Microbiology Instruments and Reagents Market
in France by Disease Area: Estimates and Projections in US$
Thousand for the Period 2020-2027 III-61

Table 89: French Clinical Microbiology Instruments and Reagents
Historic Market Scenario in US$ Thousand by Disease Area:
2012-2019 III-62

Table 90: French Clinical Microbiology Instruments and Reagents
Market Share Analysis by Disease Area: 2012 VS 2020 VS 2027 III-63

Table 91: Clinical Microbiology Instruments and Reagents
Quantitative Demand Analysis in France in US$ Thousand by
End-Use: 2020-2027 III-64

Table 92: French Clinical Microbiology Instruments and Reagents
Historic Market Review in US$ Thousand by End-Use: 2012-2019 III-65

Table 93: French Clinical Microbiology Instruments and Reagents
Market Share Analysis: A 17-Year Perspective by End-Use for
2012, 2020, and 2027 III-66

GERMANY III-67
Table 94: Clinical Microbiology Instruments and Reagents Market
in Germany: Recent Past, Current and Future Analysis in US$
Thousand by Product for the Period 2020-2027 III-67

Table 95: German Clinical Microbiology Instruments and Reagents
Historic Market Analysis in US$ Thousand by Product: 2012-2019 III-68

Table 96: German Clinical Microbiology Instruments and Reagents
Market Share Breakdown by Product: 2012 VS 2020 VS 2027 III-69

Table 97: Clinical Microbiology Instruments and Reagents Market
in Germany: Recent Past, Current and Future Analysis in US$
Thousand by Disease Area for the Period 2020-2027 III-70

Table 98: German Clinical Microbiology Instruments and Reagents
Historic Market Analysis in US$ Thousand by Disease Area:
2012-2019 III-71

Table 99: German Clinical Microbiology Instruments and Reagents
Market Share Breakdown by Disease Area: 2012 VS 2020 VS 2027 III-72

Table 100: Clinical Microbiology Instruments and Reagents
Market in Germany: Annual Sales Estimates and Forecasts in US$
Thousand by End-Use for the Period 2020-2027 III-73

Table 101: German Clinical Microbiology Instruments and
Reagents Market in Retrospect in US$ Thousand by End-Use:
2012-2019 III-74

Table 102: Clinical Microbiology Instruments and Reagents
Market Share Distribution in Germany by End-Use: 2012 VS 2020
VS 2027 III-75

ITALY III-76
Table 103: Italian Clinical Microbiology Instruments and
Reagents Market Growth Prospects in US$ Thousand by Product for
the Period 2020-2027 III-76

Table 104: Clinical Microbiology Instruments and Reagents
Historic Market Analysis in Italy in US$ Thousand by Product:
2012-2019 III-77

Table 105: Italian Clinical Microbiology Instruments and
Reagents Market by Product: Percentage Breakdown of Sales for
2012, 2020, and 2027 III-78

Table 106: Italian Clinical Microbiology Instruments and
Reagents Market Growth Prospects in US$ Thousand by Disease
Area for the Period 2020-2027 III-79

Table 107: Clinical Microbiology Instruments and Reagents
Historic Market Analysis in Italy in US$ Thousand by Disease
Area: 2012-2019 III-80

Table 108: Italian Clinical Microbiology Instruments and
Reagents Market by Disease Area: Percentage Breakdown of Sales
for 2012, 2020, and 2027 III-81

Table 109: Italian Demand for Clinical Microbiology Instruments
and Reagents in US$ Thousand by End-Use: 2020 to 2027 III-82

Table 110: Clinical Microbiology Instruments and Reagents
Market Review in Italy in US$ Thousand by End-Use: 2012-2019 III-83

Table 111: Italian Clinical Microbiology Instruments and
Reagents Market Share Breakdown by End-Use: 2012 VS 2020 VS
2027 III-84

UNITED KINGDOM III-85
Table 112: United Kingdom Market for Clinical Microbiology
Instruments and Reagents: Annual Sales Estimates and
Projections in US$ Thousand by Product for the Period 2020-2027 III-85

Table 113: Clinical Microbiology Instruments and Reagents
Market in the United Kingdom: Historic Sales Analysis in US$
Thousand by Product for the Period 2012-2019 III-86

Table 114: United Kingdom Clinical Microbiology Instruments and
Reagents Market Share Analysis by Product: 2012 VS 2020 VS 2027 III-87

Table 115: United Kingdom Market for Clinical Microbiology
Instruments and Reagents: Annual Sales Estimates and
Projections in US$ Thousand by Disease Area for the Period
2020-2027 III-88

Table 116: Clinical Microbiology Instruments and Reagents
Market in the United Kingdom: Historic Sales Analysis in US$
Thousand by Disease Area for the Period 2012-2019 III-89

Table 117: United Kingdom Clinical Microbiology Instruments and
Reagents Market Share Analysis by Disease Area: 2012 VS 2020 VS
2027 III-90

Table 118: United Kingdom Demand Estimates and Forecasts for
Clinical Microbiology Instruments and Reagents in US$ Thousand
by End-Use: 2020 to 2027 III-91

Table 119: United Kingdom Clinical Microbiology Instruments and
Reagents Market in US$ Thousand by End-Use: 2012-2019 III-92

Table 120: Clinical Microbiology Instruments and Reagents
Market Share Shift in the United Kingdom by End-Use: 2012 VS
2020 VS 2027 III-93

SPAIN III-94
Table 121: Spanish Clinical Microbiology Instruments and
Reagents Market Estimates and Forecasts in US$ Thousand by
Product: 2020 to 2027 III-94

Table 122: Spanish Clinical Microbiology Instruments and
Reagents Historic Market Review by Product in US$ Thousand:
2012-2019 III-95

Table 123: Clinical Microbiology Instruments and Reagents
Market in Spain: Percentage Share Breakdown of Sales by Product
for 2012, 2020, and 2027 III-96

Table 124: Spanish Clinical Microbiology Instruments and
Reagents Market Estimates and Forecasts in US$ Thousand by
Disease Area: 2020 to 2027 III-97

Table 125: Spanish Clinical Microbiology Instruments and
Reagents Historic Market Review by Disease Area in US$
Thousand: 2012-2019 III-98

Table 126: Clinical Microbiology Instruments and Reagents
Market in Spain: Percentage Share Breakdown of Sales by Disease
Area for 2012, 2020, and 2027 III-99

Table 127: Spanish Clinical Microbiology Instruments and
Reagents Market Quantitative Demand Analysis in US$ Thousand by
End-Use: 2020 to 2027 III-100

Table 128: Clinical Microbiology Instruments and Reagents
Market in Spain: Summarization of Historic Demand Patterns in
US$ Thousand by End-Use for 2012-2019 III-101

Table 129: Spanish Clinical Microbiology Instruments and
Reagents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 III-102

RUSSIA III-103
Table 130: Russian Clinical Microbiology Instruments and
Reagents Market Estimates and Projections in US$ Thousand by
Product: 2020 to 2027 III-103

Table 131: Clinical Microbiology Instruments and Reagents
Market in Russia by Product: A Historic Review in US$ Thousand
for 2012-2019 III-104

Table 132: Russian Clinical Microbiology Instruments and
Reagents Market Share Breakdown by Product: 2012 VS 2020 VS
2027 III-105

Table 133: Russian Clinical Microbiology Instruments and
Reagents Market Estimates and Projections in US$ Thousand by
Disease Area: 2020 to 2027 III-106

Table 134: Clinical Microbiology Instruments and Reagents
Market in Russia by Disease Area: A Historic Review in US$
Thousand for 2012-2019 III-107

Table 135: Russian Clinical Microbiology Instruments and
Reagents Market Share Breakdown by Disease Area: 2012 VS 2020
VS 2027 III-108

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957366/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001